June 22, 2017June 22, 2017
Moderate Exercise Training Improves Several SCD Features in Experimental Mice Models, Study Shows

Moderate exercise training can improve many features of sickle cell disease (SCD) in experimental mice models, including inflammation, lack ... Read more
June 20, 2017June 20, 2017
Sickle Cell Disease Association of America Receives $11.6 Million Grant for Follow–Up Services

The Health Resources and Services Administration (HRSA), part of the U.S. Department of Health and Human Services, has awarded the Sickle ... Read more
June 15, 2017June 20, 2017
Psychological Factors Can Affect Pain Sensitivity in Pediatric SCD Patients, Study Finds

Several psychological factors such as depression, anxiety, and catastrophizing (believing something is worse than it is) can influence the ... Read more
June 13, 2017
Researchers Compare PROMIS and ASCQ-Me to Measure SCD Disease Activity

A study reported that both PROMIS and ASCQ-Me measures are useful tools to monitor the daily functioning and well-being ... Read more
June 8, 2017June 8, 2017
Only 21% of Kids with ADHD and SCD Are Treated for Attention Deficit

A study of children with sickle cell disease (SCD) referred for an evaluation of neuropsychological deficits found that while ... Read more
June 6, 2017June 6, 2017
New Pre-transplant Treatment Regimen Improves Survival of Kids with Sickle Cell Disease, Trial Shows

A new pre-transplant conditioning regimen remarkably improves rejection rates and survival in children with sickle cell disease (SCD), according ... Read more
June 1, 2017June 1, 2017
Researchers Develop Test for SCA to be Used in Low-Resource Settings

Researchers have developed an accurate, low–cost potential test for diagnosing people with sickle cell anemia. The test, based on a ... Read more
May 25, 2017
Multidisciplinary Care Team Greatly Reduces Risk in Pregnant SCD Patients in Low-income Countries

According to a study published in the American Journal of Hematology, the presence of a multidisciplinary clinical team can dramatically ... Read more
May 23, 2017
FDA Advisory Committee to Review NDA for Endari as Treatment for Sickle Cell Disease

The Oncologic Drug Advisory Committee of the U.S. Food and Drug Administration (FDA) will review Emmaus Life Sciences’s New ... Read more
May 18, 2017May 18, 2017
New Method of Creating Healthy Stem Cells Could Potentially Improve Treatment of Sickle Cell Anemia

Researchers at New York’s Weill Cornell Medicine have discovered an innovative method of producing healthy stem cells that could significantly ... Read more
May 16, 2017
Imara’s IMR-687 for SCD Receives FDA Rare Pediatric Disease Designation

The U.S. Food and Drug Administration (FDA) granted rare pediatric disease designation to IMR-687, Imara’s drug candidate for the ... Read more
May 11, 2017
Phase 3 Trial Recruiting to Test Rivipansel for Vaso-Occlusive Crisis in SCD

GlycoMimetics, in collaboration with Pfizer, is now enrolling participants for a Phase 3 clinical trial to test the effectiveness ... Read more

Moderate Exercise Training Improves Several SCD Features in Experimental Mice Models, Study Shows

Moderate exercise training can improve many features of sickle cell disease (SCD) in experimental mice models, including inflammation, lack of oxygen in the blood and spleen enlargement, according to a ... Read more

June 20, 2017June 20, 2017

Sickle Cell Disease Association of America Receives $11.6 Million Grant for Follow–Up Services

The Health Resources and Services Administration (HRSA), part of the U.S. Department of Health and Human Services, has awarded the Sickle Cell Disease Association of America (SCDAA) a $2.9 million annual grant ... Read more

June 15, 2017June 20, 2017

Psychological Factors Can Affect Pain Sensitivity in Pediatric SCD Patients, Study Finds

Several psychological factors such as depression, anxiety, and catastrophizing (believing something is worse than it is) can influence the perception and experience of pain in pediatric patients with sickle ... Read more

June 13, 2017

Researchers Compare PROMIS and ASCQ-Me to Measure SCD Disease Activity

A study reported that both PROMIS and ASCQ-Me measures are useful tools to monitor the daily functioning and well-being of adults living with sickle cell disease (SCD), but most ... Read more

June 8, 2017June 8, 2017

Only 21% of Kids with ADHD and SCD Are Treated for Attention Deficit

A study of children with sickle cell disease (SCD) referred for an evaluation of neuropsychological deficits found that while 19 of 89 patients (25%) were diagnosed with attention deficit ... Read more

June 6, 2017June 6, 2017

New Pre-transplant Treatment Regimen Improves Survival of Kids with Sickle Cell Disease, Trial Shows

A new pre-transplant conditioning regimen remarkably improves rejection rates and survival in children with sickle cell disease (SCD), according to the results of Phase 1/2 trial (NCT00920972). The study, ... Read more

June 1, 2017June 1, 2017

Researchers Develop Test for SCA to be Used in Low-Resource Settings

Researchers have developed an accurate, low–cost potential test for diagnosing people with sickle cell anemia. The test, based on a lateral flow strip, is designed for use in areas where ... Read more

May 25, 2017

Multidisciplinary Care Team Greatly Reduces Risk in Pregnant SCD Patients in Low-income Countries

According to a study published in the American Journal of Hematology, the presence of a multidisciplinary clinical team can dramatically reduce maternal and perinatal mortality rates in pregnant women with sickle cell ... Read more

May 23, 2017

FDA Advisory Committee to Review NDA for Endari as Treatment for Sickle Cell Disease

The Oncologic Drug Advisory Committee of the U.S. Food and Drug Administration (FDA) will review Emmaus Life Sciences’s New Drug Application (NDA) for Endari to treat sickle cell disease ... Read more

May 18, 2017May 18, 2017

New Method of Creating Healthy Stem Cells Could Potentially Improve Treatment of Sickle Cell Anemia

Researchers at New York’s Weill Cornell Medicine have discovered an innovative method of producing healthy stem cells that could significantly improve treatment of sickle cell anemia and other blood disorders. ... Read more

May 16, 2017

Imara’s IMR-687 for SCD Receives FDA Rare Pediatric Disease Designation

The U.S. Food and Drug Administration (FDA) granted rare pediatric disease designation to IMR-687, Imara’s drug candidate for the treatment of sickle cell disease (SCD). The investigational therapy has ... Read more

May 11, 2017

Phase 3 Trial Recruiting to Test Rivipansel for Vaso-Occlusive Crisis in SCD

GlycoMimetics, in collaboration with Pfizer, is now enrolling participants for a Phase 3 clinical trial to test the effectiveness and safety of the drug candidate rivipansel (GMI-1070) for the ... Read more